---
title: "After the merger of HKC International Holdings, a 2-for-1 rights issue raised HKD 21.8 million"
description: "HKC INT'L HOLD announced a proposed 8-for-1 share consolidation. After it takes effect, a 2-for-1 rights issue will be conducted, issuing up to 77.8332 million shares; the rights issue price is HKD 0."
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/271419494.md"
published_at: "2026-01-04T10:26:56.000Z"
---

# After the merger of HKC International Holdings, a 2-for-1 rights issue raised HKD 21.8 million

> HKC INT'L HOLD announced a proposed 8-for-1 share consolidation. After it takes effect, a 2-for-1 rights issue will be conducted, issuing up to 77.8332 million shares; the rights issue price is HKD 0.28, representing a discount of 25.53% to the theoretical closing price on the last trading day (2nd). The total amount raised is HKD 21.8 million. After deducting the chairman's acceptance of the rights issue to offset shareholder loans of HKD 11.5 million, the net proceeds will be HKD 9.4 million, which is intended primarily for repaying bank loans

HKC INT'L HOLD (00248.HK) announced a proposed share consolidation of 8 for 1. After it takes effect, a rights issue will be conducted, issuing up to 77.8332 million shares; the rights issue price is HKD 0.28, representing a discount of 25.53% to the theoretical closing price on the last trading day (2nd). The total amount raised is HKD 21.8 million. After deducting the chairman's acceptance of the rights issue to offset shareholder loans of HKD 11.5 million, the net proceeds will be HKD 9.4 million, which is intended mainly for repaying bank loans

### Related Stocks

- [00248.HK - HKC INT'L HOLD](https://longbridge.com/en/quote/00248.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| HKC International Holdings Ltd. held extraordinary general meeting | HKC International Holdings Ltd. held an extraordinary general meeting on February 3, 2026, where shareholders approved a | [Link](https://longbridge.com/en/news/274636342.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/en/news/276035104.md) |
| Beijing Haizhi Technology Announces Final Offer Price | Beijing Haizhi Technology Group Co Ltd:FINAL OFFER PRICE HK$27.06 PER H SHARE UNDER GLOBAL OFFERING | [Link](https://longbridge.com/en/news/275780031.md) |
| Auto Italia taps market with share placing and HK$98m convertible bond issue | Auto Italia Holdings (HK:0720) is raising capital through a share placing and a HK$98 million convertible bond issue. Th | [Link](https://longbridge.com/en/news/275923056.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.